Acnecide face gel and face wash going GSL?

The MHRA is consulting on a proposal to make Acnecide Face 5% w/w Gel and Acnecide Face Wash 5% w/w Gel available from general sales outlets, but with more limited conditions of use than the current pharmacy products, following an application from the licence holder, Galderma UK Ltd..

The products contain 5% w/w of benzoyl peroxide N and are indicated for the treatment of mild acne in adults and adolescents aged 12 years and over.

Acnecide Face Gel and Acnecide Face Wash would be the first products containing benzoyl peroxide to be available as GSL medicines.

This deadline for responding to the consultation is 30 May 2019.

Comments (0)

This website is for healthcare professionals, people who work in pharmacy and pharmacy students. By clicking into any content, you confirm this describes you and that you agree to Pharmacy Network News's Terms of Use and Privacy Policy.

We use essential, performance, functional and advertising cookies to give you a better web experience. Find out how to manage these cookies here. We also use Interest Based Advertising Cookies to display relevant advertisements on this and other websites based on your viewing behaviour. By clicking "Accept" you agree to the use of these Cookies and our Cookie Policy.